Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126620961 | 12662096 | 1 | I | 2014 | 20140625 | 20160817 | 20160817 | PER | US-AEGERION PHARMACEUTICAL INC.-AEGR000563 | AEGERION | 52.49 | YR | M | Y | 98.87000 | KG | 20160817 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126620961 | 12662096 | 1 | PS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 5 MG, QD | 80 | MG | 203858 | 5 | MG | CAPSULE | QD | ||||
| 126620961 | 12662096 | 2 | SS | JUXTAPID | LOMITAPIDE MESYLATE | 1 | Oral | 10 MG, QD | 80 | MG | 203858 | 10 | MG | CAPSULE | QD | ||||
| 126620961 | 12662096 | 3 | SS | Hydrocodone | HYDROCODONE | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 5 | C | ASPIRIN. | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 7 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 9 | C | Hydrocodone/acetaminophen | ACETAMINOPHENHYDROCODONE | 1 | UNK | 0 | |||||||||||
| 126620961 | 12662096 | 10 | C | Omega 3 6 9 | FISH OIL | 1 | UNK | U | 0 | ||||||||||
| 126620961 | 12662096 | 11 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126620961 | 12662096 | 1 | Type IIa hyperlipidaemia |
| 126620961 | 12662096 | 3 | Pain |
| 126620961 | 12662096 | 4 | Product used for unknown indication |
| 126620961 | 12662096 | 5 | Product used for unknown indication |
| 126620961 | 12662096 | 6 | Product used for unknown indication |
| 126620961 | 12662096 | 7 | Product used for unknown indication |
| 126620961 | 12662096 | 8 | Product used for unknown indication |
| 126620961 | 12662096 | 9 | Product used for unknown indication |
| 126620961 | 12662096 | 10 | Product used for unknown indication |
| 126620961 | 12662096 | 11 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126620961 | 12662096 | Abdominal discomfort | |
| 126620961 | 12662096 | Balance disorder | |
| 126620961 | 12662096 | Constipation | |
| 126620961 | 12662096 | Diarrhoea | |
| 126620961 | 12662096 | Feeding disorder | |
| 126620961 | 12662096 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126620961 | 12662096 | 1 | 20140611 | 20141208 | 0 | |
| 126620961 | 12662096 | 2 | 20141209 | 0 | ||
| 126620961 | 12662096 | 9 | 20140626 | 0 |